UK Markets close in 6 hrs 38 mins

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
67.27-0.07 (-0.10%)
At close: 04:00PM EST
67.32 +0.05 (+0.07%)
Pre-market: 04:02AM EST
Full screen
Trade prices are not sourced from all markets
Previous close67.34
Bid0.00 x 900
Ask0.00 x 1300
Day's range67.22 - 68.69
52-week range61.39 - 74.12
Avg. volume7,784,737
Market cap84.382B
Beta (5Y monthly)0.35
PE ratio (TTM)11.51
EPS (TTM)5.84
Earnings date02 Feb 2022 - 07 Feb 2022
Forward dividend & yield2.84 (3.93%)
Ex-dividend date14 Dec 2021
1y target est76.88
  • Zacks

    Biotech Stock Roundup: VRTX Q4 Earnings, GILD, INCYs Regulatory Updates & More

    Earnings updates from Vertex (VRTX) and pipeline updates are among a few key highlights from the biotech sector during the past week.

  • Bloomberg

    Former J&J Scientist Stoffels to Lead Galapagos Revival Bid

    (Bloomberg) -- More than 20 years ago, Paul Stoffels helped form Belgian biotechnology company Galapagos NV. Now he’s headed back to lead an effort to revive it.Most Read from BloombergApple to Rival Square by Turning iPhones Into Payment TerminalsStocks Drop in Roller-Coaster Ride for Wall Street: Markets WrapPowell Backs March Liftoff, Won’t Rule Out Hike Every MeetingA Nor’easter Approaching New York Risks Becoming a Bomb CycloneJeremy Grantham Has an Even Scarier Prediction Than His Crash Ca

  • Zacks

    Gilead's (GILD) Magrolimab Studies Put on Hold by the FDA

    Gilead (GILD) efforts to build an oncology franchise get jolted as the FDA places hold on a few studies evaluating the combination of magrolimab plus azacitidine.